STOCK TITAN

William H. Miller III Trust Discloses 9.2% Position in Precigen (PGEN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

William H. Miller III Living Trust dated April 17, 2017 filed a Schedule 13G reporting beneficial ownership of 34,051,925 shares of Precigen, Inc. common stock, representing 9.2% of the class as presented in the filing. The reported amount includes 16,666,667 shares that the reporting person could acquire within 60 days upon exercise of warrants. The filing states the reporting person has sole voting and sole dispositive power over the reported shares.

The percent calculation in the filing is based on 298,455,084 shares outstanding plus an additional 54,937,411 shares delivered upon conversion of preferred stock and the 16,666,667 warrant shares referenced above. The trust certified the holdings are not intended to influence control of the issuer.

Positive

  • Substantial disclosed stake: 34,051,925 shares representing 9.2% of the class as reported
  • Sole voting and dispositive power over the reported shares, enabling clear authority over votes
  • Transparency on exercisable warrants: filing explicitly states inclusion of 16,666,667 shares exercisable within 60 days

Negative

  • None.

Insights

TL;DR: A single trust reports a meaningful ~9.2% economic stake including exercisable warrants; this is material ownership that analysts should note.

The filing discloses a significant position of 34,051,925 shares with sole voting and dispositive power, and includes 16,666,667 warrant shares exercisable within 60 days. For valuation and ownership cap-table analysis, the inclusion of exercisable warrants is important because it increases potential dilution and effective stake calculations. The filing cites a pro forma base of 298,455,084 shares plus reported conversions totaling 54,937,411 shares, which materially affects the percentage ownership denominator used.

TL;DR: The trustee holds unilateral voting and disposition authority over a sizable block; disclosure is routine but relevant for governance considerations.

The trust reports sole voting and dispositive power over the 34,051,925 shares, which signals concentrated control at the shareholder level without shared governance arrangements. The certification asserts the position is not held to influence control. From a governance perspective, a near-double-digit reported stake warrants monitoring for any future coordination, nominations, or proposals, though the filing itself contains no indication of activist intent.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Note (A) for Lines 5, 7, and 9 - Includes 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants. Note (B) for Line 11 - Based on 298,455,084 shares of Common Stock outstanding as of September 11, 2025, as reported to the Reporting Person by the Issuer's Chief Financial Officer, plus (i) an additional 54,937,411 shares of Common Stock delivered to certain holders of the Issuer's preferred stock upon the conversion of the same, as reported in the Issuer's Current Report on Form 8-K, as filed with the Securities and Exchange Commission on September 17, 2025, and (ii) an additional 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants.


SCHEDULE 13G



William H. Miller III Living Trust dated April 17, 2017
Signature:/s/ William H. Miller III
Name/Title:William H. Miller III, Trustee
Date:09/23/2025

FAQ

How many Precigen (PGEN) shares does the William H. Miller III Living Trust report owning?

The filing reports 34,051,925 shares of Precigen common stock beneficially owned by the trust.

What percent of PGEN does the trust's holding represent?

The filing states the reported position represents 9.2% of the outstanding class based on the denominators provided.

Does the filing include any shares exercisable from warrants?

Yes. The reported amount includes 16,666,667 shares that could be acquired within 60 days upon exercise of warrants.

Does the trust have voting control over the reported PGEN shares?

Yes. The trust reports sole voting power and sole dispositive power over the 34,051,925 shares.

Did the trust state an intent to influence control of Precigen (PGEN)?

The certification in Item 10 states the securities were not acquired and are not held to change or influence control of the issuer.
Precigen Inc

NASDAQ:PGEN

PGEN Rankings

PGEN Latest News

PGEN Latest SEC Filings

PGEN Stock Data

1.56B
305.62M
10.47%
66.81%
12.13%
Biotechnology
Pharmaceutical Preparations
Link
United States
GERMANTOWN